单纯疱疹病毒感染

Morris-Cunnington M, Brown D, Pimenta J, et al. New estimates of herpes simplex virus type 2 seroprevalence in England: 'high' but stable seroprevalence over the last decade. Sex Transm Dis. 2004;31:243-246.

• 摘要

Cunningham A, Diefenbach RJ, Miranda-Saksena M, et al. The cycle of human herpes simplex virus infection: viral transport and immune control. J Infect Dis. 2006;194:11-18.

• 摘要

Smith J, Robinson N. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis. 2002;186:S3-S28.

• 摘要

Austin H, Macaluso M, Nahmias A, et al. Correlates of herpes simplex virus seroprevalence among women attending a sexually transmitted disease clinic. Sex Transm Dis. 1999;26:329-334.

• 摘要

Brown ZA, Gardella C, Wald A, et al. Genital herpes complicating pregnancy. Obstet Gynecol. 2005;106:845-856.

• 摘要

Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64:1-137.

• 全文
• 摘要

Bryson YJ, Dillon M, Lovett M, et al. Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir: a randomized double-blind controlled trial in normal subjects. N Engl J Med. 1983;308:916-921.

• 摘要

Wilhelmus KR. Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev. 2015;(1):CD002898.

• 全文
• 摘要

Dylewski JS, Bekhor S. Mollaret's meningitis caused by Herpes Simplex Virus 2: case report and literature review. Eur J Clin Microbiol Infect Dis. 2004;23:560-562.

• 摘要

Kimberlin DW. Herpes simplex virus infections of the newborn. Semin Perinatol. 2007;31:19-25.

• 摘要

Jensen LA, Hoehns JD, Squires CL. Oral antivirals for the acute treatment of recurrent herpes labialis. Ann Pharmacotherapy. 2004;38:705-709.

• 摘要

1.  Baron S, ed. Medical microbiology, 4th edition. Galveston, TX: University of Texas Medical Branch at Galveston; 1996.

2.  Morris-Cunnington M, Brown D, Pimenta J, et al. New estimates of herpes simplex virus type 2 seroprevalence in England: 'high' but stable seroprevalence over the last decade. Sex Transm Dis. 2004;31:243-246.

• 摘要

3.  Bradley H, Markowitz LE, Gibson T, et al. Seroprevalence of herpes simplex virus types 1 and 2: United States, 1999-2010. J Infect Dis. 2014;209:325-333.

• 全文
• 摘要

4.  Looker KJ, Magaret AS, May MT, et al. Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PLoS One. 2015;10:e0140765.

• 全文
• 摘要

5.  Fanfair RN, Zaidi A, Taylor LD, et al. Trends in seroprevalence of herpes simplex virus type 2 among non-Hispanic blacks and non-Hispanic whites aged 14 to 49 years: United States, 1988 to 2010. Sex Transm Dis. 2013;40:860-864.

• 摘要

6.  Corey L. Wald A, Celum CL, et al. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immune Defic Syndr. 2004;35:435-445.

• 摘要

7.  Freeman E, Weiss HA, Glynn JR, et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS. 2006;20:73-83.

• 摘要

8.  Cunningham A, Diefenbach RJ, Miranda-Saksena M, et al. The cycle of human herpes simplex virus infection: viral transport and immune control. J Infect Dis. 2006;194:11-18.

• 摘要

9.  Mertz GJ, Benedetti J, Ashley R, et al. Risk factors for the sexual transmission of genital herpes. Ann Intern Med. 1992;116:197-202.

• 摘要

10.  Siegal F, Lopez C, Hammer GS, et al. Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med. 1981;305:1439-1444.

• 摘要

11.  Sullivan KM, Dykewicz CA, Longworth DL, et al. Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and beyond. Hematology Am Soc Hematol Educ Program. 2001:392-421.

• 全文
• 摘要

12.  Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA. 2006 Aug 23;296(8):964-73.

• 全文
• 摘要

13.  Smith J, Robinson N. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis. 2002;186:S3-S28.

• 摘要

14.  Austin H, Macaluso M, Nahmias A, et al. Correlates of herpes simplex virus seroprevalence among women attending a sexually transmitted disease clinic. Sex Transm Dis. 1999;26:329-334.

• 摘要

15.  Wald A, Langenberg AG, Link K, et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA. 2001;285:3100-3106.

• 全文
• 摘要

16.  Wald A, Langenberg AG, Krantz E, et al. The relationship between condom use and herpes simplex virus acquisition. Ann Intern Med. 2005;143:707-713.

• 摘要

17.  Magaret AS, Mujugira A, Hughes JP, et al. Effect of condom use on per-act HSV-2 transmission risk in HIV-1, HSV-2-discordant couples. Clin Infect Dis. 2016; 62:456-461.

• 摘要

18.  Martin ET, Krantz E, Gottlieb SL, et al. A pooled analysis of the effect of condoms in preventing HSV-2 acquisition. Arch Intern Med. 2009;169:1233-1240.

• 摘要

19.  Tobian AA, Serwadda D, Quinn TC, et al. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med. 2009;360:1298-1309.

• 全文
• 摘要

20.  Tobian AA, Kigozi G, Redd AD, et al. Male circumcision and herpes simplex virus type 2 infection in female partners: a randomized trial in Rakai, Uganda. J Infect Dis. 2012;205:486-490.

• 摘要

21.  Langenberg A, Benedetti J, Jenkins J, et al. Development of clinically recognizable genital lesions among women previously identified as having "asymptomatic" herpes simplex virus type 2 infection. Ann Intern Med. 1989;100:882-887.

• 摘要

22.  Wald A, Huang ML, Carrell D, et al. Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. J Infect Dis. 2003;188:1345-1351.

• 摘要

23.  Ross K, Johnston C, Wald A. Herpes simplex virus type 2 serological testing and psychosocial harm: a systematic review. Sex Transm Infect. 2011;87:594-600.

• 摘要

24.  Amir J, Harel L, Smetana Z, et al. The natural history of primary herpes simplex type 1 gingivostomatitis in children. Pediatric Dermatology. 1999;16:259-263.

• 摘要

25.  Spruance SL, Overall JC, Kern ER, et al. The natural history of recurrent herpes simplex labialis: implications for antiviral therapy. N Engl J Med. 1977;297:69-75.

• 摘要

26.  Brown ZA, Gardella C, Wald A, et al. Genital herpes complicating pregnancy. Obstet Gynecol. 2005;106:845-856.

• 摘要

27.  Guerry SL, Bauer HM, Klausner JD, et al. Recommendations for the selective use of herpes simplex virus type 2 serological tests. CID. 2005;40:38-45.

• 摘要

28.  Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64:1-137.

• 全文
• 摘要

29.  Sacks SL, Thisted RA, Jones TM, et al. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial. J Am Acad Dermatol. 2001;45:222-230.

• 摘要

30.  Habbema L, De Boulle K, Roders GA, et al. n-Docosanol 10% cream in the treatment of recurrent herpes labialis: a randomised, double-blind, placebo-controlled study. Acta Derm Venereol. 1996;76:479-481.

• 摘要

31.  Spruance SL, Rea TL, Thoming C, et al. Penciclovir cream for the treatment of herpes simplex labialis: a randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group. JAMA. 1997;277:1374-1379.

• 摘要

32.  Spruance SL, Nett R, Marbury T, et al. Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials. Antimicrob Agents Chemother. 2002;46:2238-2243.

• 全文
• 摘要

33.  Bryson YJ, Dillon M, Lovett M, et al. Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir: a randomized double-blind controlled trial in normal subjects. N Engl J Med. 1983;308:916-921.

• 摘要

34.  Nasser M, Fedorowicz Z, Khoshnevisan MH, et al. Acyclovir for treating primary herpetic gingivostomatitis. Cochrane Database System Rev. 2008;(4):CD006700.

• 全文
• 摘要

35.  Patel R, Alderson S, Geretti A, et al.; IUSTI/WHO Europe. European guideline for the management of genital herpes, 2010. Int J STD AIDS. 2011;22:1-10.

• 摘要

36.  Danve-Szatanek C, Aymard M, Thouvenot D, et al. Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up. J Clin Microbiol. 2004;42:242-249.

• 全文
• 摘要

37.  Gupta R, Warren T, Wald A. Genital herpes. Lancet. 2007;370:2127-2137.

• 摘要

38.  Hollier LM, Wendel GD. Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection. Cochrane Database System Rev. 2008;(1):CD004946.

• 全文
• 摘要

39.  ACOG Committee on Practice Bulletins. ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists. No. 82 June 2007. Management of herpes in pregnancy. Obstet Gynecol. 2007;109:1489-1498.

• 摘要

40.  Money D, Steben M; Society of Obstetricians and Gynecologists of Canada. Guidelines for the management of herpes simplex virus in pregnancy. J Obstet Gynaecol Can. 2008;30:514-526.

• 全文
• 摘要

41.  British Association for Sexual Health & HIV; Royal College of Obstetricians and Gynaecologists. Management of genital herpes in pregnancy. October 2014. https://www.rcog.org.uk (last accessed 7 February 2017).

• 全文

42.  Levin MJ, Bacon TH, Leary JJ. Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients. Clin Infect Dis. 2004;39(suppl 5):S248-S257.

• 全文
• 摘要

43.  Belshe RB, Leone PA, Bernstein DI, et al. Efficacy results of a trial of a herpes simplex vaccine. N Engl J Med. 2012;366:34-43.

• 摘要

44.  Tyring S, Wald A, Zadeikis N, et al. ASP2151 for the treatment of genital herpes: a randomized, double-blind, placebo- and valacyclovir-controlled, dose-finding study. J Infect Dis. 2012;205:1100-1110.

• 摘要

45.  Wald A, Corey L, Timmler B, et al. Helicase-primase inhibitor pritelivir for HSV-2 infection. N Engl J Med. 2014;370:201-210.

• 全文
• 摘要

46.  Celum C, Morrow RA, Donnell D, et al. Daily oral tenofovir and emtricitabine-tenofovir preexposure prophylaxis reduces herpes simplex virus type 2 acquisition among heterosexual HIV-1-uninfected men and women: a subgroup analysis of a randomized trial. Ann Intern Med. 2014;161:11-19.

• 摘要

47.  Bender Ignacio RA, Perti T, Magaret AS, et al. Oral and vaginal tenofovir for genital herpes simplex virus type 2 shedding in immunocompetent women: a double-blind, randomized, cross-over trial. J Infect Dis. 2015;212:1949-1956.

• 摘要

48.  Wilhelmus KR. Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev. 2015;(1):CD002898.

• 全文
• 摘要

49.  Dylewski JS, Bekhor S. Mollaret's meningitis caused by Herpes Simplex Virus 2: case report and literature review. Eur J Clin Microbiol Infect Dis. 2004;23:560-562.

• 摘要

50.  Kimberlin DW. Herpes simplex virus infections of the newborn. Semin Perinatol. 2007;31:19-25.

• 摘要

51.  Kimberlin DW, Lin CY, Jacobs RF, et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics. 2001;108:230-238.

• 摘要

52.  Lau CH, Missotten T, Salzmann J, et al. Acute retinal necrosis features, management, and outcomes. Ophthalmology. 2007;114:756-762.

• 摘要

53.  Feder HM Jr, Long SS. Herpetic whitlow: epidemiology, clinical characteristics, diagnosis, and treatment. Am J Dis Child. 1983;137:861-863.

• 摘要

54.  Jensen LA, Hoehns JD, Squires CL. Oral antivirals for the acute treatment of recurrent herpes labialis. Ann Pharmacotherapy. 2004;38:705-709.

• 摘要

55.  Baker D, Eisen D. Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-controlled studies. Cutis. 2003;71:239-242.

• 摘要